ArticleCancer research and treatment2021

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.

Yun-Gyoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.